Jump to content
AMCP Learn
Search
Open menu
Cart
AMCP Learn login
Register
Bookmark/Search this post
Facebook
X
LinkedIn
Forward
Home
Catalog
Training Programs
Help
Contact Us
FAQ
You are here
Home
Search
RWE Essentials Training Program - Provider & Health Plan Version
RWE Module 4: Study Design and Methodologies
RWE Module 9: Operationalizing the AMCP RWE Standards for Formulary Impact
Tuesday, 4/14 - Sessions from 10:15-11:30am
(D1) Next-Generation HIV PrEP: Therapeutic Advances, Adherence Optimization, and Policy Updates for Managed Care
(L1) The Fine Print of Affordability: What Employers and PBMs Need to Know About Cost-Shifting Strategies
(M1) Oncology in Focus: What’s Hot, What’s Next!
(R1) RWE in Action: Using the AMCP RWE Standards to Facilitate Formulary Decisions
(W1) Beyond the Buzzwords: Lessons Learned in Bridging Pharmacy, Quality, AI, and Data Science to Improve Performance
Tuesday, 4/14 - Sessions from 1:30-2:45pm
(D2) Beyond the Breakthrough: Practical Insights for the Complex Gene Therapy Market
(L2) Federal Legislative and Regulatory Update
(M2) The Accelerated Approval Program: Balancing Crucial Patient Access with Timely Evidentiary Needs
(R2) Launch to Lessons Learned: Real-World Experience with Adalimumab Biosimilars
(W2) Driving Quality in Oncology Medication Use Through Precision Medicine
Tuesday, 4/14 - Sessions from 3:15-4:15pm
(F3) Mission Possible: How Integrated Medical & Pharmacy Benefits Can Improve Specialty Drug Management
(L3) An Enterprise Solution for Mental Health Parity Compliance
(W3) Patient Experience Data in Managed Care Pharmacy Decision Making: Barriers, Opportunities, and Practical Strategies for Managed Care Pharmacists
(K1) 2025-2026 Health Care and Pharmaceutical Marketplace Trends
Wednesday, 4/15 - Sessions from 10:15-11:30am
(F4) Advancing Patient-Centered Care in Narcolepsy Type 1: Integrating the Latest Evidence, Guidelines, and Treatment Innovations
(D4) Digesting the Disruption: Biosimilars, Benefits, and Barriers in IBD Care
(M4) Drug Pipeline: Traditional Pharmaceuticals (Brands and Generics) and Biosimilars
(R4) Leveraging Mortality Data for Real-World Evidence in Managed Care: Challenges and Potential Solutions
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
next ›
last »
Search
Home
Catalog
Training Programs
Help
Contact Us
FAQ
Facebook
X
LinkedIn
Forward